Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

Third Ebola Vaccine to Start Human Trials Next Year

 / Updated 

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

Researchers have scheduled human tests on a third possible Ebola vaccine in response to the U.N.'s call to fast-track treatments for the worst known outbreak of the deadly virus in human history.

Johnson & Johnson said in a statement early Thursday it would begin human trials early next year of a vaccine derived from technologies created by Crucell N.V. of the Netherlands and the Danish biotech company Bavarian Nordic. "In light of the current emergency in West Africa and given the evident, huge unmet medical need, we are stepping up our efforts and accelerating the Ebola program," said Johan Van Hoof, global head of infectious disease and vaccine programs for Crucell.

GlaxoSmithKline has already said it will begin trials this month on its potential vaccine, and trials on a vaccine being developed by the Canadian government could begin later this year.

IN-DEPTH

— M. Alex Johnson

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
MORE FROM news

Have feedback?

How likely are you to recommend nbcnews.com to a friend or colleague?

0 = Very unlikely
10 = Very likely
Please select answer

Is your feedback about:

Please select answer

Thank you!

Your feedback has been sent out. Please enjoy more of our content.

We appreciate your help making nbcnews.com a better place.